Cancer Epidemiology Biomarkers & Prevention · 2006 · 65 citations · 12 references
MedicineOncologyPathologyCancer GeneticsMolecular OncologyNeoplasiaCancer CytogeneticsCancer Genomic InstabilityCancer Survival AnalysisMalignant NeoplasmsMolecular Tumor ProfilingTumor ClassificationBreast Cancer Molecular SubtypesBreast Cancer PrognosisDna Content MeasurementGenomic Instability AssessmentPloidy VariationProgesterone Receptor StatusPrognostic ClassificationPrognostic Value Of Grade
BACKGROUND: We recently reported that DNA content of breast adenocarcinomas, cytometrically assessed by diploid (D), tetraploid (T), and aneuploid (A) categories, can be further divided into genomically stable and unstable subtypes by means of the stemline scatter index (SSI). The aim of the present study was to survey the clinical correlates and the prognostic value of the SSI in a consecutive series of 890 breast cancer patients. RESULTS: Genomically stable subtype had a significantly better survival compared with the unstable subtype within each ploidy category: D (P = 0.04), T (P = 0.008), and A (P = 0.004). By contrast, no statistically significant difference in survival was observed between the D, T, and A categories within the stable (P = 0.23) and unstable subtypes (P = 0.12). Among A tumors, the unstable subtype tended to be larger, more frequently estrogen- and progesterone-receptor negative, and to be of higher grade compared with the stable subtype. Stable D tumors tended to have lower grade than the unstable subtype, but among the D and T tumors, genomic instability was not associated with receptor status. Within the Elston grade 3, lymph node-positive or estrogen receptor-positive subgroups, patients with stable tumors had significantly better survival compared with unstable tumors (P = 0.01, 0.002, and 7.2E-5, respectively). CONCLUSIONS: The SSI contributes supplementary biological and clinical information in addition to ploidy information alone. Objective classification of breast adenocarcinomas into stable and unstable subtypes is a useful prognostic indicator independent of established clinical factors.
12
DNA content and survival in mammary carcinoma.
Gert Auer, T. Caspersson, Ame Wallgren · PubMed · 1980 · 369 citations
MULTIPLE GENETIC ALTERATIONS IN DISTAL AND PROXIMAL COLORECTAL CANCER
Olivier Delattre, David Law, Yorghos Remvikos et al. · The Lancet · 1989 · 303 citations · Full text
Kerstin Heselmeyer, Merryn Macville, Evelin Schröck et al. · Genes Chromosomes and Cancer · 1997 · 265 citations
Life Sciences, Genetics, Oncology +16
Thomas Ried, K E Just, Heidi Holtgreve-Grez et al. · PubMed · 1995 · 232 citations
Life Sciences, Genetics, Pathology +17